Las Vegas, NV -- (SBWIRE) -- 01/29/2013 -- PennyStockParlay.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Amgen, Inc. (NASDAQ:AMGN) shares jumped 2.60% and closed at $85.59 in the last trading session. The company, on Jan. 26, announced results from Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES), a Phase 3 trial which evaluated Neulasta(® )(pegfilgrastim) in 845 patients receiving FOLFOX or FOLFIRI and bevacizumab for the first-line treatment of locally-advanced or metastatic colorectal cancer. FOLFOX and FOLFIRI are two of the most commonly used chemotherapy regimens for colorectal cancer.
Should Investors Buy AMGN After The Recent Drop? Find Out Here
Biogen Idec Inc. (NASDAQ:BIIB) shares gained 2.59% to $149.99 after the company posted lower fourth-quarter GAAP net income of $292.13 million, versus last year's $300.24 million, while earnings per share improved to $1.23, from $1.22 in 2011. On a non-GAAP basis, net income attributable to Biogen Idec amounted to $335 million, or $1.40 per share for the latest period. Analysts expected earnings per share of $1.46 for the quarter. Quarterly total revenues totaled $1.42 billion, an increase from $1.33 billion in the prior-year quarter, whereas analysts estimated revenues of $1.39 billion for the quarter.
We Have A Free Trend Analysis on BIIB, Find Out Here
Crocs, Inc. (NASDAQ:CROX) shares climbed 2.56% and closed at $15.23. The company recently the company disclosed in an SEC filing that it had experienced a "difficult holiday retail sales environment" last year. The company, however, reiterated its previous fourth quarter revenue guidance of $220M. Analysts' consensus estimate was $219.38M. Crocs estimated that its backlog for the first half of 2013 would increase 15% versus the same period in 2012 on a nominal basis, and said its new products were "well accepted in most markets."
Get More latest News, Rumors and Updates On CROX Here
Hertz Global Holdings, Inc. (NYSE:HTZ) shares increased 2.54% to $18.58 in yesterday’s session. The company, on Jan. 17, announced that Hertz Vehicle Financing LLC ("HVF"), a special purpose bankruptcy remote limited liability company of which The Hertz Corporation ("Hertz" or the "Company"), a wholly-owned subsidiary of Hertz Holdings, is the sole member, priced $950 million in aggregate principal amount of three year and five year Series 2013-1 Rental Car Asset Backed Notes, Class A and Class B, rated "Aaa" and "Baa2" by Moody's, respectively.
How To Trade HTZ Now After The Recent Volatile Moves? Find Out Here
Cypress Semiconductor Corporation (NASDAQ:CY) shares increased 2.53% to $10.12. The company, on Jan. 24, reported a fourth-quarter net loss of $24.21 million or $0.17 per share compared to profit of $31.66 million or $0.18 per share last year. Adjusted net income per share attributable to Cypress for the quarter was $0.05. Analysts expected the company to report profit of $0.04 per share for the quarter. Revenues decreased to $180.28 million from $242.37 million last year. All divisions decreased on a year-on-year basis. Analysts expected revenue of $178.08 million for the quarter.
Don’t Forget To Get Your Free Trend Analysis Here
PennyStockParlay.com has been successful in bringing Stock Parlay members with top penny stock newsletter. Stock Parlay’s staff and penny stocks exploration methods have proved 100% accurate in finding the best penny stocks move in e-mail alerts. PennyStockParlay.com works all day and night to find the best penny stock picks portfolio through penny stock newsletter. PennyStockParlay.com has kept winning members with top penny stock newsletter.
The assembled information disseminated by PennyStockParlay.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. PennyStockParlay.com does expect that investors will buy and sell securities based on information assembled and presented in PennyStockParlay.com. Please always do due diligence; consult a financial advisor before buying or selling stocks.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)